tenk.fyi

Silexion Therapeutics Corp

SLXNNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

-

Net Income

-$16.5M

223.4% YoY

EPS

$26.36

40.4% YoY

Cash

$1.2M

74.2% YoY

FY 2024 · As of 2024-12-31